The yield curve continues to flatten as the Federal Reserve stays on the sidelines, making it hard for investors to gain sufficient income in their bond portfolios. Collin Martin, director of fixed income at Schwab (SCHW) Center for Financial Research, advises against reaching for yield, especially in riskier asset classes like high yield. 'We don't like high yield from a tactical standpoint too much right now,' said Martin. 'We think investors should stick with their long term allocations.' The Fed met earlier this week and kept their benchmark rate on hold. The updated projections had a dovish tilt, in Martin's opinion. Although the median projection for 2016 remained steady, more participants were in the one hike only camp. 'We still think one or maybe two hikes are possible this year, but the bar is certainly higher now,' said Martin. 'It reiterates that we're in a lower for longer rate cycle.'
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.